Answers are grounded in this paper and cite their sources.
To minimize the premature drug release of nanocarriers, we have developed chemically cross-linked bioreducible polymersomes (CLPMs) that can specifically release the drug inside cancer cells.
No takes yet. Share an insight, caveat, or question.
Thambi et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: